Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma
Clinical trial NCT04555577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04555577
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-20
- Primary completion
- 2027-12-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.